Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01703572
Title A Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors OncoMed Pharmaceuticals, Inc.
Indications

lymphoma

leukemia

Therapies

Brontictuzumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.